The classic Ajax logo will officially return as the club's emblem starting from season 2025/2026. As a result, the classic ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Branding experts weigh in on Vistara's sky-high standards in delivering consumer experience, which built its reputation as a uniquely Indian luxury brand ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

HCWB also has a payment-free, milestone-free, and royalty-free option to recapture the development and commercialization rights of this molecule for the U.S., Canada, Central America, and South ...

India's markets regulator on Thursday published a study that showed a jump in payment of royalty by listed companies and ...

Starting on Nov. 15, 2024, X will use everything you post to train its AI. Here's how to deactivate your X account.

It’s a jungle out there. Deriving the right royalty rate for new pharmaceuticals and biotechnologies is a real tangle. This is a critical business function, and it has never been more important ...

Aug. 21, 2024 at 12:16 p.m. ET on GuruFocus.com ...

X got an update to its terms of service on November 15 that grants the site permission to train AI with user data. It's ...

The financing is being led by Vivo Capital and includes participation by new and existing investors including Forge Life ...

Hardman & Co Research Hardman & Co Research on Duke Capital (DUKE): Taking Duke Capital to the next level 18-Nov-2024 / 13:20 GMT/BST The issuer is solely responsible for the content of this ...